Asensus Surgical Inc (NASDAQ:ASXC) shares are trading higher after the company collaborated with NVIDIA Corp (NASDAQ: NVDA).
The collaboration aims to accelerate the development of Asensus’s Intelligent Surgical Unit (ISU) and improve its ability to deliver novel clinical intelligence to surgeons.
Asensus will utilize a broad suite of NVIDIA tools to enhance the augmented intelligence capabilities of its ISU.
Asensus’s ISU is built with NVIDIA accelerated computing technology and has brought real-time augmented intelligent features — such as digital tags, 3D measurement, and enhanced camera control — to surgeons since 2021.
“We’re thrilled to collaborate with NVIDIA to enhance the machine vision and image analytics capabilities of the ISU, as well as the processing speed and precision of its augmented intelligence capabilities. Utilizing NVIDIA’s advanced technologies will allow us to further improve the ISU’s augmented intelligence capabilities and the roadmap of our innovative clinical applications,” said Anthony Fernando, Asensus Surgical President and CEO.
As part of the collaboration, both companies will have early access to relevant product roadmaps, fostering synergistic development. Furthermore, Asensus and NVIDIA plan to jointly define business models for developing, deploying, and commercializing digital surgical solutions.
Price Action: ASXC shares are up 16.30% at $0.34 on the last check Thursday.
